ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma

C. L. Batlevi, Y. Kasamon, R. G. Bociek, P. Lee, L. Gore, A. Copeland, R. Sorensen, P. Ordentlich, S. Cruickshank, L. Kunkel, D. Buglio, F. Hernandez-Ilizaliturri, A. Younes

Open source

DOI: 10.3324/haematol.2016.142406
Published: 2016-05-05
Container: Haematologica
Publisher: Ferrata Storti Foundation (Haematologica)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2016.142406,
  title = {ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma},
  author = {C. L. Batlevi and Y. Kasamon and R. G. Bociek and P. Lee and L. Gore and A. Copeland and R. Sorensen and P. Ordentlich and S. Cruickshank and L. Kunkel and D. Buglio and F. Hernandez-Ilizaliturri and A. Younes},
  year = {2016},
  journal = {Haematologica},
  doi = {10.3324/haematol.2016.142406},
  url = {https://doi.org/10.3324/haematol.2016.142406}
}

RIS

TY  - JOUR
TI  - ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
AU  - C. L. Batlevi
AU  - Y. Kasamon
AU  - R. G. Bociek
AU  - P. Lee
AU  - L. Gore
AU  - A. Copeland
AU  - R. Sorensen
AU  - P. Ordentlich
AU  - S. Cruickshank
AU  - L. Kunkel
AU  - D. Buglio
AU  - F. Hernandez-Ilizaliturri
AU  - A. Younes
PY  - 2016
JO  - Haematologica
DO  - 10.3324/haematol.2016.142406
UR  - https://doi.org/10.3324/haematol.2016.142406
ER  -

APA

Batlevi, C. L., Kasamon, Y., Bociek, R. G., Lee, P., Gore, L., Copeland, A., Sorensen, R., Ordentlich, P., Cruickshank, S., Kunkel, L., Buglio, D., Hernandez-Ilizaliturri, F., & Younes, A. (2016). ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma. Haematologica. https://doi.org/10.3324/haematol.2016.142406

Source records

crossref · retrieved 2026-09-26T03:23:55.580Z